Rigel Pharmaceuticals (RIGL) Gross Profit (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.09% |
| Dec 31, 2025 | -1.33% |
| Sep 30, 2025 | -33.41% |
| Jun 30, 2025 | 98.64% |
| Mar 31, 2025 | -5.56% |
| Dec 31, 2024 | 9.57% |
| Sep 30, 2024 | 38.92% |
| Jun 30, 2024 | 23.72% |
| Mar 31, 2024 | -14.04% |
| Dec 31, 2023 | 19.12% |
| Sep 30, 2023 | 4.09% |
| Jun 30, 2023 | 2.86% |
| Mar 31, 2023 | -50.74% |
| Dec 31, 2022 | 129.86% |
| Sep 30, 2022 | -23.01% |
| Jun 30, 2022 | 73.25% |
| Mar 31, 2022 | -16.60% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -18.15% |
| Jun 30, 2021 | -67.61% |
| Mar 31, 2021 | 345.15% |
| Dec 31, 2020 | -0.66% |
| Sep 30, 2020 | 15.93% |
| Jun 30, 2020 | -71.69% |
| Mar 31, 2020 | 265.30% |
| Dec 31, 2019 | -25.92% |
| Sep 30, 2019 | 103.52% |
| Jun 30, 2019 | -19.34% |
| Mar 31, 2019 | -66.77% |
| Dec 31, 2018 | 685.43% |
| Sep 30, 2018 | 172.97% |